
|Articles|March 15, 2003
Posterior chamber phakic IOLs appear safe for moderate, high myopia
Orlando-Posterior chamber phakic implants can offer safe and effective correction of moderate to high myopia with stable refractive outcomes, low risks of operative and postoperative complications, high patient satisfaction, and the benefit of less induction of optical aberrations relative to LASIK, according to James J. Salz, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program
2
Treating myopia today: US-focused treatments, challenges, and global insights
3
US FDA awards Epion Therapeutics EpiSmart cross-linking system Fast Track designation
4
Ophthalmology over the decades: A catalyst of innovation in the 1970s
5